720 related articles for article (PubMed ID: 17353435)
1. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
Eckle T; Krahn T; Grenz A; Köhler D; Mittelbronn M; Ledent C; Jacobson MA; Osswald H; Thompson LF; Unertl K; Eltzschig HK
Circulation; 2007 Mar; 115(12):1581-90. PubMed ID: 17353435
[TBL] [Abstract][Full Text] [Related]
2. Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
Grenz A; Zhang H; Eckle T; Mittelbronn M; Wehrmann M; Köhle C; Kloor D; Thompson LF; Osswald H; Eltzschig HK
J Am Soc Nephrol; 2007 Mar; 18(3):833-45. PubMed ID: 17267736
[TBL] [Abstract][Full Text] [Related]
3. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning.
Hart ML; Much C; Gorzolla IC; Schittenhelm J; Kloor D; Stahl GL; Eltzschig HK
Gastroenterology; 2008 Nov; 135(5):1739-1750.e3. PubMed ID: 18804111
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning.
Wolff G; Truse R; Decking U
PLoS One; 2015; 10(8):e0135086. PubMed ID: 26261991
[TBL] [Abstract][Full Text] [Related]
5. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice.
Montesinos MC; Takedachi M; Thompson LF; Wilder TF; Fernández P; Cronstein BN
Arthritis Rheum; 2007 May; 56(5):1440-5. PubMed ID: 17469101
[TBL] [Abstract][Full Text] [Related]
6. Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo.
Huang DY; Vallon V; Zimmermann H; Koszalka P; Schrader J; Osswald H
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F282-8. PubMed ID: 16525161
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.
Hart ML; Grenz A; Gorzolla IC; Schittenhelm J; Dalton JH; Eltzschig HK
J Immunol; 2011 Apr; 186(7):4367-74. PubMed ID: 21357264
[TBL] [Abstract][Full Text] [Related]
8. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
[TBL] [Abstract][Full Text] [Related]
9. IFN-beta protects from vascular leakage via up-regulation of CD73.
Kiss J; Yegutkin GG; Koskinen K; Savunen T; Jalkanen S; Salmi M
Eur J Immunol; 2007 Dec; 37(12):3334-8. PubMed ID: 18034430
[TBL] [Abstract][Full Text] [Related]
10. CD73/ecto-5'-nucleotidase protects against vascular inflammation and neointima formation.
Zernecke A; Bidzhekov K; Ozüyaman B; Fraemohs L; Liehn EA; Lüscher-Firzlaff JM; Lüscher B; Schrader J; Weber C
Circulation; 2006 May; 113(17):2120-7. PubMed ID: 16636171
[TBL] [Abstract][Full Text] [Related]
11. Ecto-5' nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy.
Hasegawa T; Bouïs D; Liao H; Visovatti SH; Pinsky DJ
Circ Res; 2008 Dec; 103(12):1410-21. PubMed ID: 19008478
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response.
Koszalka P; Ozüyaman B; Huo Y; Zernecke A; Flögel U; Braun N; Buchheiser A; Decking UK; Smith ML; Sévigny J; Gear A; Weber AA; Molojavyi A; Ding Z; Weber C; Ley K; Zimmermann H; Gödecke A; Schrader J
Circ Res; 2004 Oct; 95(8):814-21. PubMed ID: 15358667
[TBL] [Abstract][Full Text] [Related]
13. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
14. In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.
Choukèr A; Ohta A; Martignoni A; Lukashev D; Zacharia LC; Jackson EK; Schnermann J; Ward JM; Kaufmann I; Klaunberg B; Sitkovsky MV; Thiel M
Transplantation; 2012 Nov; 94(9):894-902. PubMed ID: 23073466
[TBL] [Abstract][Full Text] [Related]
15. Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain.
Petrovic-Djergovic D; Hyman MC; Ray JJ; Bouis D; Visovatti SH; Hayasaki T; Pinsky DJ
J Immunol; 2012 Mar; 188(5):2387-98. PubMed ID: 22291183
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.
Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
J Clin Invest; 1994 May; 93(5):2197-205. PubMed ID: 8182151
[TBL] [Abstract][Full Text] [Related]
17. A2b adenosine receptors in cardioprotection: timing is everything.
Methner C; Krieg T
J Mol Cell Cardiol; 2011 Mar; 50(3):582-3. PubMed ID: 21050857
[No Abstract] [Full Text] [Related]
18. Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury.
Hart ML; Jacobi B; Schittenhelm J; Henn M; Eltzschig HK
J Immunol; 2009 Apr; 182(7):3965-8. PubMed ID: 19299692
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia.
Grenz A; Zhang H; Weingart J; von Wietersheim S; Eckle T; Schnermann J; Köhle C; Kloor D; Gleiter CH; Vallon V; Eltzschig HK; Osswald H
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1501-11. PubMed ID: 17855480
[TBL] [Abstract][Full Text] [Related]
20. CD73-generated adenosine promotes osteoblast differentiation.
Takedachi M; Oohara H; Smith BJ; Iyama M; Kobashi M; Maeda K; Long CL; Humphrey MB; Stoecker BJ; Toyosawa S; Thompson LF; Murakami S
J Cell Physiol; 2012 Jun; 227(6):2622-31. PubMed ID: 21882189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
